GGrantIndex
Sort

46,585 grants matching heart failure

Self-regulating continuous-flow total artificial heart

$1,288,622
Kiyotaka Fukamachi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · HL

Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases

$1,288,595
Kenneth R Chien · Massachusetts General Hospital · U01 · FY2011 · HL

Enhancer regulation by H3K4 methyltransferase MLL4/KMT2D and associated factors

$1,286,836
Kai Ge · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study

$1,286,326
Christine M Albert · Brigham And Women'S Hospital · R01 · FY2014 · HL

SHePREG: Study of Heart function in PRE-Eclampsia during and after PreGnancy

$1,284,381
Elisa Ann Bradley · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · HL

REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients

$1,284,025
Dalane W Kitzman · Wake Forest University Health Sciences · R01 · FY2018 · AG

Whole-Room Calorimeter

$1,284,000
Arlene B Chapman · University Of Chicago · S10 · FY2022 · OD

RSK3-MAKAP TARGETING AS A NEW THERAPEUTIC STRATEGY FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION IN WOMEN

$1,281,479
University Of Missouri System · · FY2018 · Department of the Army

Atherosclerosis Risk in Communities Study (ARIC)

$1,281,292
Gerardo Heiss · Univ Of North Carolina Chapel Hill · N01 · FY2009 · HL

Look AHEAD: Action for Health in Diabetes

$1,280,593
Thomas A. Wadden · University Of Pennsylvania · U01 · FY2007 · DK

Development of a Minimally Invasive Single Cannulation, Compact Single Port Pulsatile Ventricular Assist Device (sppVAD) for Total LV Support

$1,280,230
Stephen R Topaz · W-Z Biotech, Llc · R44 · FY2024 · HL

Automated Long-Term Oxygen Therapy Control System

$1,279,500
Nick Rydberg · Minnesota Healthsolutions Corporation · R44 · FY2023 · HL

The PREVENTABLE Physical Performance Ancillary Study

$1,279,277
Denise Kathryn Houston · Wake Forest University Health Sciences · R01 · FY2022 · AG

An automated portable system for detecting and treating opioid induced respiratory depression

$1,278,121
Kenneth P. Mackie · Trustees Of Indiana University · U01 · FY2023 · DA

Cardiac Biomarkers in Pediatric Cardiomyopathy

$1,277,688
Steven Edward Lipshultz · University Of Miami School Of Medicine · R01 · FY2013 · HL

Registry of Mechanical Circulatory Support Devices for End-State Heart Failure

$1,277,005
M.d., James, K. Kirklin · University Of Alabama At Birmingham · N01 · FY2009 · HL

Hypergen: Genetics of Left Ventricular Hypertrophy

$1,276,399
Donna K. Arnett · University Of Alabama At Birmingham · R01 · FY2008 · HL

Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases

$1,275,404
Kevin Kit Parker · Massachusetts General Hospital · U01 · FY2014 · HL

The complex genetics of heart regeneration

$1,273,956
Henry M Sucov · Medical University Of South Carolina · R01 · FY2025 · HL

Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases

$1,272,877
Kenneth R Chien · Massachusetts General Hospital · U01 · FY2010 · HL

Hypertrophic Cardiomyopathy: Understanding the Heterogeneity of Disease Expression and Outcomes

$1,272,161
Carolyn Y Ho · Brigham And Women'S Hospital · R01 · FY2024 · HL

Influence of Prenatal and Early Childhood Home-Visiting by Nurses on Development of Chronic Disease: 29-year Follow-Up of a Randomized Clinical Trial

$1,271,096
David L Olds · University Of Colorado Denver · R01 · FY2023 · HL

CHS Events Follow-up Study

$1,268,677
Bruce M Psaty · University Of Washington · R01 · FY2012 · HL

Executing the IND-Enabling Studies for Oral PCSK9/LDLR antagonist

$1,267,886
Nabil A Elshourbagy · Shifa Biomedical Corporation · R44 · FY2024 · HL

Immunobiology and immunotherapy of leukemia

$1,267,777
Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL